Intragastric Balloons Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type, by Filling Material, by End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Key Market Dynamics 

The increasing obesity rates stem from various factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. As these factors become more prevalent globally, the incidence of obesity continues to rise. Obesity is associated with numerous health complications including cardiovascular diseases, diabetes, and certain types of cancer. Consequently, individuals are increasingly seeking effective weight loss solutions to mitigate these health risks and improve their overall well-being. This growing demand for obesity management solutions drives the market for interventions such as intragastric balloons, which offer a minimally invasive approach to weight loss. 

However, limited reimbursement policies hinder the adoption of intragastric balloons. In many healthcare systems, the coverage for intragastric balloon procedures may be insufficient or non-existent, resulting in high out-of-pocket costs for patients. This financial barrier can deter individuals from seeking treatment, particularly those with limited financial resources or inadequate insurance coverage. Consequently, the potential for intragastric balloons market forecast is constrained, as the lack of reimbursement hampers accessibility and affordability for a significant portion of the target population. 

Furthermore, an opportunity lies in the growing emphasis on lifestyle modification as a key component of obesity management. Healthcare providers and public health initiatives increasingly advocate for lifestyle changes including dietary modifications, regular exercise, and behavior therapy to address obesity and its associated health risks. Intragastric balloons can complement these efforts by providing a temporary aid to weight loss while patients undergo lifestyle modifications. This integrated approach offers a holistic solution to obesity management, addressing both the physical and behavioral aspects of weight loss. By aligning with the focus on lifestyle modification, intragastric balloons can capitalize on this opportunity to expand their market reach and promote sustainable weight loss outcomes. 

Prevalence Statistics of Obesity for Global Intragastric Balloons Market 

According to the World Health Organization (WHO) in 2024, obesity prevalence was a significant concern across age groups, with alarming figures reported for both adults and adolescents. Among adults, an estimated 650 million individuals were affected by obesity, thus highlighting the widespread nature of this health issue. Additionally, approximately 340 million adolescents struggled with obesity, highlighting the critical need for intervention during this crucial stage of development. These statistics emphasize the urgent need for efforts to combat obesity and promote healthier lifestyles, thereby highlighting the relevance and importance of the global intragastric balloons market in addressing this pressing public health challenge. 

Market Segmentation 

The intragastric balloons industry is segmented into type, filling material, end user, and region. By type, the market is segmented into single, dual, and triple. By filling material, it is bifurcated into gas filled and saline filled. By end user, it is categorized into hospitals, ambulatory surgical centers (ASC) , and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Regional/Country Market Outlook 

In North America, the intragastric balloons market share is expected to witness robust growth driven by increasing obesity rates, rising healthcare expenditure, and favorable reimbursement policies. Technological advancements and growing acceptance of minimally invasive weight loss treatments further contribute to market expansion. Similarly, Europe exhibits significant market potential with supportive regulatory frameworks and a growing emphasis on preventive healthcare measures. In the Asia-Pacific region, rapid urbanization, change in lifestyles, and increase in awareness of obesity-related health risks fuel intragastric balloons market growth, while emerging economies in Latin America and the Middle East & Africa present untapped opportunities for market penetration and growth. 

• Allurion Technologies, Inc. continued its worldwide expansion with the launch of the Allurion Program in Canada, Mexico, Australia, and Brazil. In the U.S., Allurion launched the AUDACITY trial, an open-label, pivotal study to evaluate the safety and efficacy of the Allurion Balloon plus Moderate Intensity Lifestyle Modification Therapy Program (or “MILMTP”) versus MILMTP alone in the U.S. patients. 
• According to a report published by the Trust for America's Health Organization in 2021, the U.S. adult obesity rate represents more than 42.4%, and it is the first time the national rate has passed the 40.0% mark. The national adult obesity rate has increased by 26.0% in previous years. 
• In September 2023, ReShape Lifesciences Inc., the premier physician-led weight loss and metabolic health solutions company, announced the signing of an exclusive, royalty-bearing license agreement with Biorad Medysis, Pvt. Ltd. (Biorad) to manufacture, commercialize and distribute the Obalon Gastric Balloon System in India, Pakistan, Bangladesh, Nepal, Bhutan, Sri Lanka, and the Maldives. 

Industry Trends 

• In February 2022, an article published in the National Institute of Health, stated that in the studied population, about 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment. 
• In 2020, Allurion Technologies Inc. raised $34 million to facilitate the launch of its swallowable weight loss balloon. 

Competitive Landscape 

The major players operating in the intragastric balloons market size include Obalon Therapeutics, Apollo Endosurgery Inc., Allurion Technologies Inc., Spatz Medical, ReShape Lifesciences, Lexel Medical, Endalis, MEDSIL, and Silimed.  Other players in intragastric balloons market includes Districlass Medical, Helioscopie, and so on. 

Recent Key Strategies and Developments 

• In September 2022, Allurion Technologies, the U.S.-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks  
• In November 2022, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Apollo Endosurgery, Inc. for a cash price of $10 per share, reflecting an enterprise value of approximately $615 million. 
• In June 2023, Allurion, a company dedicated to ending obesity, today announced a pilot collaboration agreement with Medtronic, a global leader in healthcare technology, to expand access to Allurion’s AI-powered weight loss program through a sales agency agreement in the Central and Eastern Europe, Middle East, and Africa (CEMA) region. The partnership enables Allurion to offer the Allurion Balloon and accelerate utilization of the Allurion Iris Artificial Intelligence (AI) Platform in the management of bariatric surgery patients by leveraging Medtronic channels during the collaboration.  

Key Sources Referred 

• World Health Organization (WHO)  
• National Center for Biotechnology and Information (NCBI)  
• Centers for Medicare & Medicaid Services (CMS)  
• National Health Service (NHS)  
• Ministry of Health and Family Welfare (MoHFW)  
• National Health Mission (NHM)  
• Allurion Technologies 
• Medtronic Plc 
• Centers for Disease Control and Prevention (CDC)  
• Food and Drug Administration (FDA)  
• National Institutes of Health (NIH)

  Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intragastric balloons market analysis from 2024 to 2033 to identify the prevailing intragastric balloons market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the intragastric balloons market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

• The report includes the analysis of the regional as well as global intragastric balloons market trends, key players, market segments, application areas, and market growth strategies.